Michael J. Birrer, MD of Massachusetts General Hospital discusses HPV-related cervical cancer with anti-PD-1 and anti-PDL-1 antibodies at SGO 2016.
So I think from a theoretical standpoint. Cervical cancer should be the poster child for immunotherapy. I sencha understand these tumors. Result in infection from HP vis vis vis vis genome is there E. seven any six are usually expressed these are foreign and agents these are viral infections. So if the immune system is. Op inactivated. Ended tumors producing some of these in him dory prophecies if you use an anti PDL-1 one or anti PD-1 you should. Wake up the immune system and it should be effective.